← Back to Search

Aromatherapy for Nausea and Vomiting

Phase 2

Waitlist Available

Led By Debbie Anglade, PhD

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Symptoms of nausea or vomiting after the first chemotherapy infusion

Receiving three or more remaining cycles of chemotherapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial will study whether aromatherapy can help reduce chemotherapy side effects like nausea and vomiting.

Who is the study for?

This trial is for cancer survivors over 18 who can understand English or Spanish, are undergoing moderate to high emetogenic chemotherapy with at least three cycles left, and have experienced nausea or vomiting after their first infusion. It's not for those with hormone-sensitive cancers, olfactory disorders, sensitivity to essential oils, receiving their first chemo cycle, or on low emetogenic regimens.Check my eligibility

What is being tested?

The study compares the effectiveness of aromatherapy versus standard care in reducing nausea and vomiting caused by certain chemotherapy treatments. Participants will receive either the usual anti-nausea medication along with aromatherapy or just the standard treatment without aromatherapy.See study design

What are the potential side effects?

While standard anti-nausea medications can cause headaches, constipation, and dizziness; aromatherapy may lead to allergic reactions or skin irritation in some individuals sensitive to essential oils.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I experienced nausea or vomiting after my first chemotherapy session.

Select...

I have three or more chemotherapy sessions left.

Select...

I am receiving chemotherapy that often causes vomiting.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in severity of Chemotherapy-Induced Nausea and Vomiting (CINV)

Secondary outcome measures

Change in frequency of Antiemetic Medication

Type of antiemetic medications

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard of Care With Study InterventionExperimental Treatment2 Interventions

Participants will receive an aromatherapy inhaler for complementary in addition to their standard of care antiemetic medication for Chemotherapy-Induced Nausea and Vomiting (CINV).

Group II: Standard of Care With No Study InterventionActive Control1 Intervention

Participants will receive standard medical care, consisting of antiemetic medicine at the first sign of Chemotherapy-Induced Nausea and Vomiting (CINV) on a schedule as prescribed by the healthcare provider.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor

899 Previous Clinical Trials

409,582 Total Patients Enrolled

Debbie Anglade, PhDPrincipal InvestigatorUniversity of Miami

1 Previous Clinical Trials

16 Total Patients Enrolled

Media Library

Aromatherapy Care Clinical Trial Eligibility Overview. Trial Name: NCT05319860 — Phase 2

Nausea and Vomiting Research Study Groups: Standard of Care With No Study Intervention, Standard of Care With Study Intervention

Nausea and Vomiting Clinical Trial 2023: Aromatherapy Care Highlights & Side Effects. Trial Name: NCT05319860 — Phase 2

Aromatherapy Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319860 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What possible risks are associated with using aromatherapy treatments?

"Aromatherapy Care received a score of 2 because, while there is some evidence that it is safe, none exists to support that it is effective."

Answered by AI

Are there any patients that qualify for this research program at the moment?

"Unfortunately, this particular trial is not recruiting patients as of right now. According to the latest update on clinicaltrials.gov (8/31/2022), this study was initially posted on 8/1/2022. Although this specific trial may not be seeking candidates, there are 120 other trials that are currently looking for patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

Debbie Anglade, PhD, MSN, RN 2022. "Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05319860.